Bone and Joint Health, Blizard Institute, Queen Mary University of London, London, UK.
Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Oxford, UK.
Cochrane Database Syst Rev. 2022 Feb 14;2(2):CD013404. doi: 10.1002/14651858.CD013404.pub2.
Hip fractures are a major healthcare problem, presenting a considerable challenge and burden to individuals and healthcare systems. The number of hip fractures globally is rising rapidly. The majority of intracapsular hip fractures are treated surgically.
To assess the relative effects (benefits and harms) of all surgical treatments used in the management of intracapsular hip fractures in older adults, using a network meta-analysis of randomised trials, and to generate a hierarchy of interventions according to their outcomes.
We searched CENTRAL, MEDLINE, Embase, Web of Science, and five other databases in July 2020. We also searched clinical trials databases, conference proceedings, reference lists of retrieved articles and conducted backward-citation searches.
We included randomised controlled trials (RCTs) and quasi-RCTs comparing different treatments for fragility intracapsular hip fractures in older adults. We included total hip arthroplasties (THAs), hemiarthroplasties (HAs), internal fixation, and non-operative treatments. We excluded studies of people with hip fracture with specific pathologies other than osteoporosis or resulting from high-energy trauma.
Two review authors independently assessed studies for inclusion. One review author completed data extraction which was checked by a second review author. We collected data for three outcomes at different time points: mortality and health-related quality of life (HRQoL) - both reported within 4 months, at 12 months, and after 24 months of surgery, and unplanned return to theatre (at end of study follow-up). We performed a network meta-analysis (NMA) with Stata software, using frequentist methods, and calculated the differences between treatments using risk ratios (RRs) and standardised mean differences (SMDs) and their corresponding 95% confidence intervals (CIs). We also performed direct comparisons using the same codes.
We included 119 studies (102 RCTS, 17 quasi-RCTs) with 17,653 participants with 17,669 intracapsular fractures in the review; 83% of fractures were displaced. The mean participant age ranged from 60 to 87 years and 73% were women. After discussion with clinical experts, we selected 12 nodes that represented the best balance between clinical plausibility and efficiency of the networks: cemented modern unipolar HA, dynamic fixed angle plate, uncemented first-generation bipolar HA, uncemented modern bipolar HA, cemented modern bipolar HA, uncemented first-generation unipolar HA, uncemented modern unipolar HA, THA with single articulation, dual-mobility THA, pins, screws, and non-operative treatment. Seventy-five studies (with 11,855 participants) with data for at least two of these treatments contributed to the NMA. We selected cemented modern unipolar HA as a reference treatment against which other treatments were compared. This was a common treatment in the networks, providing a clinically appropriate comparison. In order to provide a concise summary of the results, we report only network estimates when there was evidence of difference between treatments. We downgraded the certainty of the evidence for serious and very serious risks of bias and when estimates included possible transitivity, particularly for internal fixation which included more undisplaced fractures. We also downgraded for incoherence, or inconsistency in indirect estimates, although this affected few estimates. Most estimates included the possibility of benefits and harms, and we downgraded the evidence for these treatments for imprecision. We found that cemented modern unipolar HA, dynamic fixed angle plate and pins seemed to have the greatest likelihood of reducing mortality at 12 months. Overall, 23.5% of participants who received the reference treatment died within 12 months of surgery. Uncemented modern bipolar HA had higher mortality than the reference treatment (RR 1.37, 95% CI 1.02 to 1.85; derived only from indirect evidence; low-certainty evidence), and THA with single articulation also had higher mortality (network estimate RR 1.62, 95% CI 1.13 to 2.32; derived from direct evidence from 2 studies with 225 participants, and indirect evidence; very low-certainty evidence). In the remaining treatments, the certainty of the evidence ranged from low to very low, and we noted no evidence of any differences in mortality at 12 months. We found that THA (single articulation), cemented modern bipolar HA and uncemented modern bipolar HA seemed to have the greatest likelihood of improving HRQoL at 12 months. This network was comparatively sparse compared to other outcomes and the certainty of the evidence of differences between treatments was very low. We noted no evidence of any differences in HRQoL at 12 months, although estimates were imprecise. We found that arthroplasty treatments seemed to have a greater likelihood of reducing unplanned return to theatre than internal fixation and non-operative treatment. We estimated that 4.3% of participants who received the reference treatment returned to theatre during the study follow-up. Compared to this treatment, we found low-certainty evidence that more participants returned to theatre if they were treated with a dynamic fixed angle plate (network estimate RR 4.63, 95% CI 2.94 to 7.30; from direct evidence from 1 study with 190 participants, and indirect evidence). We found very low-certainty evidence that more participants returned to theatre when treated with pins (RR 4.16, 95% CI 2.53 to 6.84; only from indirect evidence), screws (network estimate RR 5.04, 95% CI 3.25 to 7.82; from direct evidence from 2 studies with 278 participants, and indirect evidence), and non-operative treatment (RR 5.41, 95% CI 1.80 to 16.26; only from indirect evidence). There was very low-certainty evidence of a tendency for an increased risk of unplanned return to theatre for all of the arthroplasty treatments, and in particular for THA, compared with cemented modern unipolar HA, with little evidence to suggest the size of this difference varied strongly between the arthroplasty treatments.
AUTHORS' CONCLUSIONS: There was considerable variability in the ranking of each treatment such that there was no one outstanding, or subset of outstanding, superior treatments. However, cemented modern arthroplasties tended to more often yield better outcomes than alternative treatments and may be a more successful approach than internal fixation. There is no evidence of a difference between THA (single articulation) and cemented modern unipolar HA in the outcomes measured in this review. THA may be an appropriate treatment for a subset of people with intracapsular fracture but we have not explored this further.
髋部骨折是一个主要的医疗保健问题,给个人和医疗系统带来了相当大的挑战和负担。全球髋部骨折的数量正在迅速增加。大多数囊内髋部骨折需要手术治疗。
使用随机试验的网络荟萃分析评估所有用于治疗老年囊内髋部骨折的手术治疗的相对效果(益处和危害),并根据其结果对干预措施进行分层。
我们于 2020 年 7 月在 CENTRAL、MEDLINE、Embase、Web of Science 和其他五个数据库中进行了检索。我们还检索了临床试验数据库、会议论文集、检索文章的参考文献列表,并进行了回溯引文搜索。
我们纳入了比较不同治疗方法治疗老年囊内髋部骨折的随机对照试验(RCT)和准 RCT。我们纳入了全髋关节置换术(THA)、半髋关节置换术(HA)、内固定和非手术治疗。我们排除了研究髋部骨折有特定病理,而不是骨质疏松症或由高能创伤引起的研究。
两位综述作者独立评估研究纳入情况。一位综述作者完成数据提取,另一位综述作者进行核对。我们在不同时间点收集了三个结局的数据:死亡率和健康相关生活质量(HRQoL)-均在手术后 4 个月、12 个月和 24 个月内报告,以及计划外再次手术(研究随访结束时)。我们使用 Stata 软件进行了网络荟萃分析(NMA),使用了似然法,并使用风险比(RR)和标准化平均差异(SMD)及其相应的 95%置信区间(CI)计算了治疗之间的差异。我们还使用相同的代码进行了直接比较。
我们纳入了 119 项研究(102 项 RCT,17 项准 RCT),涉及 17653 名囊内骨折患者;83%的骨折为移位性骨折。参与者的平均年龄范围为 60 至 87 岁,73%为女性。在与临床专家讨论后,我们选择了 12 个节点,这些节点代表了网络中临床合理性和效率之间的最佳平衡:骨水泥固定的现代单关节 HA、动力固定角度板、非骨水泥第一代双极 HA、非骨水泥现代双极 HA、骨水泥固定的现代双极 HA、非骨水泥第一代单极 HA、非骨水泥现代单极 HA、单关节 THA、双动式 THA、钉、螺钉和非手术治疗。75 项(涉及 11855 名参与者)至少有两种这些治疗方法的数据的研究为 NMA 做出了贡献。我们选择了骨水泥固定的现代单关节 HA 作为参考治疗,与其他治疗方法进行了比较。这是网络中常见的治疗方法,提供了一个合适的临床比较。为了简明扼要地总结结果,我们仅在存在治疗方法之间差异的证据时报告网络估计值。我们对严重和非常严重的偏倚风险的证据进行了降级,并对包括可能的转换性的估计进行了降级,特别是对于包括更多未移位骨折的内固定。我们还对内聚性或间接估计不一致进行了降级,尽管这对少数估计有影响。大多数估计都包括了益处和危害的可能性,我们对这些治疗方法的精确性进行了降级。我们发现骨水泥固定的现代单关节 HA、动力固定角度板和钉似乎更有可能降低 12 个月时的死亡率。总的来说,接受参考治疗的参与者中有 23.5%在手术后 12 个月内死亡。非骨水泥固定的现代双极 HA 的死亡率高于参考治疗(RR 1.37,95%CI 1.02 至 1.85;仅来自间接证据;低质量证据),THA 也有更高的死亡率(网络估计 RR 1.62,95%CI 1.13 至 2.32;来自 2 项研究的直接证据,每项研究有 225 名参与者,以及间接证据;非常低质量证据)。在其余的治疗中,证据的确定性范围从低到非常低,我们没有发现 12 个月时死亡率有任何差异的证据。我们发现 THA(单关节)、骨水泥固定的现代双极 HA 和非骨水泥固定的现代双极 HA 似乎更有可能在 12 个月时改善 HRQoL。与其他结局相比,这个网络相对稀疏,治疗方法之间差异的证据确定性非常低。我们没有发现 12 个月时 HRQoL 有任何差异的证据,尽管估计不太准确。我们发现关节置换术似乎比内固定和非手术治疗更有可能减少计划外再次手术。我们估计,接受参考治疗的参与者中有 4.3%在研究随访期间返回手术室。与这种治疗方法相比,我们发现低质量证据表明,与骨水泥固定的现代单关节 HA 相比,更多参与者如果接受动力固定角度板治疗(网络估计 RR 4.63,95%CI 2.94 至 7.30;来自 1 项研究的直接证据,该研究有 190 名参与者,以及间接证据)会返回手术室。我们发现非常低质量的证据表明,与内固定和非手术治疗相比,更多参与者如果接受钉(RR 4.16,95%CI 2.53 至 6.84;仅来自间接证据)、螺钉(网络估计 RR 5.04,95%CI 3.25 至 7.82;来自 2 项研究的直接证据,每项研究有 278 名参与者,以及间接证据)或非手术治疗(RR 5.41,95%CI 1.80 至 16.26;仅来自间接证据)返回手术室的可能性更大。有非常低质量的证据表明,与骨水泥固定的现代单关节 HA 相比,所有关节置换术的计划外再次手术风险都有增加的趋势,而且特别是与 THA 相比,这种差异的大小似乎在关节置换术之间没有强烈的差异。
每种治疗方法的排名都存在很大差异,因此没有一种治疗方法是绝对优秀或突出的。然而,与替代治疗方法相比,骨水泥固定的现代关节置换术往往更能产生更好的结果,并且可能比内固定更有效。在本综述中测量的结果没有证据表明 THA(单关节)和骨水泥固定的现代单关节 HA 之间有差异。THA 可能是囊内骨折患者的一种合适的治疗方法,但我们尚未对此进行进一步探讨。